EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses... Show more
ESLOY saw its Momentum Indicator move above the 0 level on August 07, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at .
ESLOY moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ESLOY crossed bullishly above the 50-day moving average on July 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ESLOY advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 278 cases where ESLOY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for ESLOY moved out of overbought territory on July 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where ESLOY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ESLOY turned negative on August 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESLOY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ESLOY broke above its upper Bollinger Band on July 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.088) is normal, around the industry mean (10.661). P/E Ratio (49.189) is within average values for comparable stocks, (62.050). Projected Growth (PEG Ratio) (2.668) is also within normal values, averaging (1.847). Dividend Yield (0.015) settles around the average of (0.016) among similar stocks. P/S Ratio (4.294) is also within normal values, averaging (83.916).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ESLOY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.
Ticker / NAME | Correlation To ESLOY | 1D Price Change % | ||
---|---|---|---|---|
ESLOY | 100% | +0.39% | ||
ESLOF - ESLOY | 58% Loosely correlated | +0.21% | ||
SMMNY - ESLOY | 41% Loosely correlated | +0.82% | ||
SAUHY - ESLOY | 37% Loosely correlated | -1.11% | ||
CLPBY - ESLOY | 33% Poorly correlated | -1.05% | ||
LZAGY - ESLOY | 32% Poorly correlated | -1.21% | ||
More |
Ticker / NAME | Correlation To ESLOY | 1D Price Change % |
---|---|---|
ESLOY | 100% | +0.39% |
Pharmaceuticals category (394 stocks) | 36% Loosely correlated | +1.08% |
Pharmaceuticals: Other category (105 stocks) | 31% Poorly correlated | +1.19% |